Selected research
Industry Growth & Trends
Global NTA-IDA Chelating Ligands Industry Growth and Trends Forecast to 2032
Market perspective
The global NTA-IDA Chelating Ligands market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for NTA-IDA Chelating Ligands is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of NTA-IDA Chelating Ligands include Merck, Bio-Rad, Bio-Works, Macherey-Nagel, Cube Biotech, G-Biosciences, GenScript, BestChrom and NanoMicro, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global NTA-IDA Chelating Ligands market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The NTA-IDA Chelating Ligands market size, estimates, and forecasts are presented in terms of sales volume (t) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global NTA-IDA Chelating Ligands market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to NTA-IDA Chelating Ligands.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global NTA-IDA Chelating Ligands market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
NTA-IDA Chelating Ligands Market by Company
Merck
Bio-Rad
Bio-Works
Macherey-Nagel
Cube Biotech
G-Biosciences
GenScript
BestChrom
NanoMicro
Duoning Biotech
Smart-Lifesciences
Resindion
Cytiva
Thermo Fisher Scientific
Qiagen
NTA-IDA Chelating Ligands Segment by Type
NTA Chelating Ligand
IDA Chelating Ligand
NTA and IDA Screening Set
Other IMAC Chelating Ligand
NTA-IDA Chelating Ligands Segment by Application
His-Tagged Protein Purification
Process Development and Scale-Up
Metal-Binding Protein Enrichment
Phosphopeptide Enrichment
Metal Ion Removal
Other Research Use
NTA-IDA Chelating Ligands Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NTA-IDA Chelating Ligands market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of NTA-IDA Chelating Ligands and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NTA-IDA Chelating Ligands.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of NTA-IDA Chelating Ligands manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of NTA-IDA Chelating Ligands in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- NTA Chelating Ligand
- IDA Chelating Ligand
- NTA and IDA Screening Set
- Other IMAC Chelating Ligand
Applications
- His-Tagged Protein Purification
- Process Development and Scale-Up
- Metal-Binding Protein Enrichment
- Phosphopeptide Enrichment
- Metal Ion Removal
- Other Research Use
Companies covered
- Merck
- Bio-Rad
- Bio-Works
- Macherey-Nagel
- Cube Biotech
- G-Biosciences
- GenScript
- BestChrom
- NanoMicro
- Duoning Biotech
- Smart-Lifesciences
- Resindion
- Cytiva
- Thermo Fisher Scientific
- Qiagen
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global NTA-IDA Chelating Ligands Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global NTA-IDA Chelating Ligands Sales Estimates and Forecasts (2021-2032)
- 1.3 NTA-IDA Chelating Ligands Market by Type
- 1.3.1 NTA Chelating Ligand
- 1.3.2 IDA Chelating Ligand
- 1.3.3 NTA and IDA Screening Set
- 1.3.4 Other IMAC Chelating Ligand
- 1.4 Global NTA-IDA Chelating Ligands Market Size by Type
- 1.4.1 Global NTA-IDA Chelating Ligands Market Size Overview by Type (2021-2032)
- 1.4.2 Global NTA-IDA Chelating Ligands Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global NTA-IDA Chelating Ligands Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America NTA-IDA Chelating Ligands Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe NTA-IDA Chelating Ligands Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific NTA-IDA Chelating Ligands Sales Breakdown by Type (2021-2026)
- 1.5.4 South America NTA-IDA Chelating Ligands Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa NTA-IDA Chelating Ligands Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 NTA-IDA Chelating Ligands Industry Trends
- 2.2 NTA-IDA Chelating Ligands Industry Drivers
- 2.3 NTA-IDA Chelating Ligands Industry Opportunities and Challenges
- 2.4 NTA-IDA Chelating Ligands Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by NTA-IDA Chelating Ligands Revenue (2021-2026)
- 3.2 Global Top Players by NTA-IDA Chelating Ligands Sales (2021-2026)
- 3.3 Global Top Players by NTA-IDA Chelating Ligands Price (2021-2026)
- 3.4 Global NTA-IDA Chelating Ligands Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global NTA-IDA Chelating Ligands Major Company Production Sites & Headquarters
- 3.6 Global NTA-IDA Chelating Ligands Company, Product Type & Application
- 3.7 Global NTA-IDA Chelating Ligands Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global NTA-IDA Chelating Ligands Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 NTA-IDA Chelating Ligands Players Market Share by Revenue in 2025
- 3.8.3 2025 NTA-IDA Chelating Ligands Tier 1, Tier 2, and Tier 3
4 NTA-IDA Chelating Ligands Regional Status and Outlook
- 4.1 Global NTA-IDA Chelating Ligands Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global NTA-IDA Chelating Ligands Historic Market Size by Region
- 4.2.1 Global NTA-IDA Chelating Ligands Sales in Volume by Region (2021-2026)
- 4.2.2 Global NTA-IDA Chelating Ligands Sales in Value by Region (2021-2026)
- 4.2.3 Global NTA-IDA Chelating Ligands Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global NTA-IDA Chelating Ligands Forecasted Market Size by Region
- 4.3.1 Global NTA-IDA Chelating Ligands Sales in Volume by Region (2027-2032)
- 4.3.2 Global NTA-IDA Chelating Ligands Sales in Value by Region (2027-2032)
- 4.3.3 Global NTA-IDA Chelating Ligands Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 NTA-IDA Chelating Ligands by Application
- 5.1 NTA-IDA Chelating Ligands Market by Application
- 5.1.1 His-Tagged Protein Purification
- 5.1.2 Process Development and Scale-Up
- 5.1.3 Metal-Binding Protein Enrichment
- 5.1.4 Phosphopeptide Enrichment
- 5.1.5 Metal Ion Removal
- 5.1.6 Other Research Use
- 5.2 Global NTA-IDA Chelating Ligands Market Size by Application
- 5.2.1 Global NTA-IDA Chelating Ligands Market Size Overview by Application (2021-2032)
- 5.2.2 Global NTA-IDA Chelating Ligands Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global NTA-IDA Chelating Ligands Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America NTA-IDA Chelating Ligands Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe NTA-IDA Chelating Ligands Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific NTA-IDA Chelating Ligands Sales Breakdown by Application (2021-2026)
- 5.3.4 South America NTA-IDA Chelating Ligands Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa NTA-IDA Chelating Ligands Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Merck
- 6.1.1 Merck Company Information
- 6.1.2 Merck Business Overview
- 6.1.3 Merck NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Merck NTA-IDA Chelating Ligands Product Portfolio
- 6.1.5 Merck Recent Developments
- 6.2 Bio-Rad
- 6.2.1 Bio-Rad Company Information
- 6.2.2 Bio-Rad Business Overview
- 6.2.3 Bio-Rad NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Bio-Rad NTA-IDA Chelating Ligands Product Portfolio
- 6.2.5 Bio-Rad Recent Developments
- 6.3 Bio-Works
- 6.3.1 Bio-Works Company Information
- 6.3.2 Bio-Works Business Overview
- 6.3.3 Bio-Works NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Bio-Works NTA-IDA Chelating Ligands Product Portfolio
- 6.3.5 Bio-Works Recent Developments
- 6.4 Macherey-Nagel
- 6.4.1 Macherey-Nagel Company Information
- 6.4.2 Macherey-Nagel Business Overview
- 6.4.3 Macherey-Nagel NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Macherey-Nagel NTA-IDA Chelating Ligands Product Portfolio
- 6.4.5 Macherey-Nagel Recent Developments
- 6.5 Cube Biotech
- 6.5.1 Cube Biotech Company Information
- 6.5.2 Cube Biotech Business Overview
- 6.5.3 Cube Biotech NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Cube Biotech NTA-IDA Chelating Ligands Product Portfolio
- 6.5.5 Cube Biotech Recent Developments
- 6.6 G-Biosciences
- 6.6.1 G-Biosciences Company Information
- 6.6.2 G-Biosciences Business Overview
- 6.6.3 G-Biosciences NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 G-Biosciences NTA-IDA Chelating Ligands Product Portfolio
- 6.6.5 G-Biosciences Recent Developments
- 6.7 GenScript
- 6.7.1 GenScript Company Information
- 6.7.2 GenScript Business Overview
- 6.7.3 GenScript NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 GenScript NTA-IDA Chelating Ligands Product Portfolio
- 6.7.5 GenScript Recent Developments
- 6.8 BestChrom
- 6.8.1 BestChrom Company Information
- 6.8.2 BestChrom Business Overview
- 6.8.3 BestChrom NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 BestChrom NTA-IDA Chelating Ligands Product Portfolio
- 6.8.5 BestChrom Recent Developments
- 6.9 NanoMicro
- 6.9.1 NanoMicro Company Information
- 6.9.2 NanoMicro Business Overview
- 6.9.3 NanoMicro NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 NanoMicro NTA-IDA Chelating Ligands Product Portfolio
- 6.9.5 NanoMicro Recent Developments
- 6.10 Duoning Biotech
- 6.10.1 Duoning Biotech Company Information
- 6.10.2 Duoning Biotech Business Overview
- 6.10.3 Duoning Biotech NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 Duoning Biotech NTA-IDA Chelating Ligands Product Portfolio
- 6.10.5 Duoning Biotech Recent Developments
- 6.11 Smart-Lifesciences
- 6.11.1 Smart-Lifesciences Company Information
- 6.11.2 Smart-Lifesciences Business Overview
- 6.11.3 Smart-Lifesciences NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Smart-Lifesciences NTA-IDA Chelating Ligands Product Portfolio
- 6.11.5 Smart-Lifesciences Recent Developments
- 6.12 Resindion
- 6.12.1 Resindion Company Information
- 6.12.2 Resindion Business Overview
- 6.12.3 Resindion NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Resindion NTA-IDA Chelating Ligands Product Portfolio
- 6.12.5 Resindion Recent Developments
- 6.13 Cytiva
- 6.13.1 Cytiva Company Information
- 6.13.2 Cytiva Business Overview
- 6.13.3 Cytiva NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 Cytiva NTA-IDA Chelating Ligands Product Portfolio
- 6.13.5 Cytiva Recent Developments
- 6.14 Thermo Fisher Scientific
- 6.14.1 Thermo Fisher Scientific Company Information
- 6.14.2 Thermo Fisher Scientific Business Overview
- 6.14.3 Thermo Fisher Scientific NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.14.4 Thermo Fisher Scientific NTA-IDA Chelating Ligands Product Portfolio
- 6.14.5 Thermo Fisher Scientific Recent Developments
- 6.15 Qiagen
- 6.15.1 Qiagen Company Information
- 6.15.2 Qiagen Business Overview
- 6.15.3 Qiagen NTA-IDA Chelating Ligands Sales, Revenue and Gross Margin (2021-2026)
- 6.15.4 Qiagen NTA-IDA Chelating Ligands Product Portfolio
- 6.15.5 Qiagen Recent Developments
7 North America by Country
- 7.1 North America NTA-IDA Chelating Ligands Sales by Country
- 7.1.1 North America NTA-IDA Chelating Ligands Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America NTA-IDA Chelating Ligands Sales by Country (2021-2026)
- 7.1.3 North America NTA-IDA Chelating Ligands Sales Forecast by Country (2027-2032)
- 7.2 North America NTA-IDA Chelating Ligands Market Size by Country
- 7.2.1 North America NTA-IDA Chelating Ligands Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America NTA-IDA Chelating Ligands Market Size by Country (2021-2026)
- 7.2.3 North America NTA-IDA Chelating Ligands Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe NTA-IDA Chelating Ligands Sales by Country
- 8.1.1 Europe NTA-IDA Chelating Ligands Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe NTA-IDA Chelating Ligands Sales by Country (2021-2026)
- 8.1.3 Europe NTA-IDA Chelating Ligands Sales Forecast by Country (2027-2032)
- 8.2 Europe NTA-IDA Chelating Ligands Market Size by Country
- 8.2.1 Europe NTA-IDA Chelating Ligands Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe NTA-IDA Chelating Ligands Market Size by Country (2021-2026)
- 8.2.3 Europe NTA-IDA Chelating Ligands Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific NTA-IDA Chelating Ligands Sales by Country
- 9.1.1 Asia-Pacific NTA-IDA Chelating Ligands Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific NTA-IDA Chelating Ligands Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific NTA-IDA Chelating Ligands Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific NTA-IDA Chelating Ligands Market Size by Country
- 9.2.1 Asia-Pacific NTA-IDA Chelating Ligands Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific NTA-IDA Chelating Ligands Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific NTA-IDA Chelating Ligands Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America NTA-IDA Chelating Ligands Sales by Country
- 10.1.1 South America NTA-IDA Chelating Ligands Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America NTA-IDA Chelating Ligands Sales by Country (2021-2026)
- 10.1.3 South America NTA-IDA Chelating Ligands Sales Forecast by Country (2027-2032)
- 10.2 South America NTA-IDA Chelating Ligands Market Size by Country
- 10.2.1 South America NTA-IDA Chelating Ligands Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America NTA-IDA Chelating Ligands Market Size by Country (2021-2026)
- 10.2.3 South America NTA-IDA Chelating Ligands Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa NTA-IDA Chelating Ligands Sales by Country
- 11.1.1 Middle East and Africa NTA-IDA Chelating Ligands Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa NTA-IDA Chelating Ligands Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa NTA-IDA Chelating Ligands Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa NTA-IDA Chelating Ligands Market Size by Country
- 11.2.1 Middle East and Africa NTA-IDA Chelating Ligands Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa NTA-IDA Chelating Ligands Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa NTA-IDA Chelating Ligands Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 NTA-IDA Chelating Ligands Value Chain Analysis
- 12.1.1 NTA-IDA Chelating Ligands Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 NTA-IDA Chelating Ligands Production Mode & Process
- 12.2 NTA-IDA Chelating Ligands Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 NTA-IDA Chelating Ligands Distributors
- 12.2.3 NTA-IDA Chelating Ligands Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst